Overall rank by patents
#31,196
of 49,997 tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 13 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).
The verdict
According to USPTO PatentsView, China ranks #31,196 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 13 technology areas.
USPTO PatentsView assignee plate
Corpus R31196 · Foreign Corporation #31,196 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Chilisin Electronics Corp. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
China National Rice… · this assignee
48 score
3D Lighting… · lowest
7 score
What this shows China's Innovation Score is 47.5/100 (top 18% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
China National Rice Research Institute is a focused PatentsView assignee: 13 CPC subclasses with 50% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2024 (3 grants) versus a trough of 1 in 2018. By volume, China sits between Chilisin Electronics Corp. and CHO Pharma, Inc..
China National Rice Research Institute shows 5 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Chilisin Electronics Corp.
8 patents
China Construction Industrial & Energy Engineering Group Co., Ltd
8 patents
China Construction Steel Structure Co., Ltd.
8 patents
China General Nuclear Power Group
8 patents
China Resources Microelectronics (CHONGQING) Co., Ltd.
8 patents
Chinese Academy OF Inspection AND Quarantine
8 patents
Chiome Bioscience Inc.
8 patents
CHO Pharma, Inc.
8 patents
China National Rice Research Institute
8 patents
What this shows China holds 8 patents at rank #31,156, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #31,156 in granted patent volume.
Other assignees with the most granted patents in China's primary technology class.
China's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
48 Top 18% higher than 82% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 2 | 25.0% |
| 2018 | 1 | 12.5% |
| 2023 | 2 | 25.0% |
| 2024 | 3 | 37.5% |
Top 13 of 13 technology areas
Overall rank by patents
#31,196
of 49,997 tracked assignees
47.5 out of 100
What to do with this data
China National Rice Research Institute's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.